The use of systemic chemotherapy before definitive locoregional management, or induction
chemotherapy, has been a theoretically attractive and well-studied approach in the …

Монография посвящена сложной проблеме клинической онкологии-лечению,
реабилитации и качеству жизни больных раком гортани после комбинированного …

Objectives To (1) determine clinical factors that predict pathologic complete response (pCR)
on neck dissection after sequential chemoradiotherapy (SCRT) for advanced head and neck …

Head and neck cancers are a complex group of diseases defined by variations in
histological features, anatomical location, and cause. Once the realm of surgeons and …

In the absence of large‐scale randomized trials evaluating dissection versus observation of
the involved neck after neoadjuvant chemoradiotherapy, there is a need to collect data that …

The epidermal growth factor (EGF) and its receptor were discovered nearly 40 years ago.
Over the past decade interruption of this pathway has been exploited in the treatment of …

BACKGROUND AND PURPOSE: Concomitant chemoradiation is more and more used for
advanced head and neck cancer. It improves local control and survival compared to …

OBJECTIVE: The purpose of the study is to evaluate dysphagia severity following
chemoradiation and postoperative radiation for head and neck cancer, and particularly the …

Aims and Background To compare conventional fractionation (CF) radiation therapy (RT),
arm A, versus a split-course accelerated hyperfractionated schedule (S-AHF), arm B, versus …

Background. Postopertative adjuvant chemoradiotherapy recently became an established
modality for patients with selected high‐risk locally advanced head and neck cancers. The …